FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098839608> ?p ?o ?g. }

• W2098839608 endingPage "60" @default.
• W2098839608 startingPage "53" @default.
• W2098839608 abstract "Background Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. Objectives (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. Methods All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. Results There were 167 heart transplant recipients, of which 16 (9.5%) developed AF and another 25 (15.0%) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6% ± 1.6% vs 62.5% ± 1.5%, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.3–6.6, p < 0.008) but not AF (HR, 2.264; 95% CI, 0.72–7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95% CI, 1.38–5.96; p < 0.004), age at transplant (HR, 1.04; 95% CI, 1.00–1.07, p < 0.03), coronary artery disease (HR, 2.655; 95% CI, 1.25–5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95% CI 2.37–10.62; p < 0.001), right atrial volume index (HR, 1.03; 95% CI, 1.00–10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Conclusion Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome. Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. There were 167 heart transplant recipients, of which 16 (9.5%) developed AF and another 25 (15.0%) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6% ± 1.6% vs 62.5% ± 1.5%, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.3–6.6, p < 0.008) but not AF (HR, 2.264; 95% CI, 0.72–7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95% CI, 1.38–5.96; p < 0.004), age at transplant (HR, 1.04; 95% CI, 1.00–1.07, p < 0.03), coronary artery disease (HR, 2.655; 95% CI, 1.25–5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95% CI 2.37–10.62; p < 0.001), right atrial volume index (HR, 1.03; 95% CI, 1.00–10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome." @default.
• W2098839608 created "2016-06-24" @default.
• W2098839608 creator A5009859448 @default.
• W2098839608 creator A5018965634 @default.
• W2098839608 creator A5021517283 @default.
• W2098839608 creator A5029899326 @default.
• W2098839608 creator A5036732236 @default.
• W2098839608 creator A5043850889 @default.
• W2098839608 creator A5053399122 @default.
• W2098839608 creator A5059576786 @default.
• W2098839608 creator A5076834694 @default.
• W2098839608 creator A5077814849 @default.
• W2098839608 creator A5086835868 @default.
• W2098839608 creator A5088432263 @default.
• W2098839608 date "2006-01-01" @default.
• W2098839608 modified "2023-10-16" @default.
• W2098839608 title "Prevalence, Pathophysiology, and Clinical Significance of Post-heart Transplant Atrial Fibrillation and Atrial Flutter" @default.
• W2098839608 cites W1966738745 @default.
• W2098839608 cites W1970706076 @default.
• W2098839608 cites W1979225436 @default.
• W2098839608 cites W1983459562 @default.
• W2098839608 cites W1984069702 @default.
• W2098839608 cites W1989619973 @default.
• W2098839608 cites W2001674341 @default.
• W2098839608 cites W2002428895 @default.
• W2098839608 cites W2006565016 @default.
• W2098839608 cites W2009537427 @default.
• W2098839608 cites W2022518830 @default.
• W2098839608 cites W2033989169 @default.
• W2098839608 cites W203408500 @default.
• W2098839608 cites W2037416972 @default.
• W2098839608 cites W2040471283 @default.
• W2098839608 cites W2050370911 @default.
• W2098839608 cites W2075992531 @default.
• W2098839608 cites W2136800284 @default.
• W2098839608 cites W2170208798 @default.
• W2098839608 cites W2223214578 @default.
• W2098839608 cites W2286243256 @default.
• W2098839608 cites W2397738019 @default.
• W2098839608 cites W2397757272 @default.
• W2098839608 cites W2404066465 @default.
• W2098839608 cites W2413252767 @default.
• W2098839608 cites W2431294349 @default.
• W2098839608 cites W2472890309 @default.
• W2098839608 cites W57419316 @default.
• W2098839608 doi "https://doi.org/10.1016/j.healun.2005.07.017" @default.
• W2098839608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16399531" @default.
• W2098839608 hasPublicationYear "2006" @default.
• W2098839608 type Work @default.
• W2098839608 sameAs 2098839608 @default.
• W2098839608 citedByCount "76" @default.
• W2098839608 countsByYear W20988396082012 @default.
• W2098839608 countsByYear W20988396082013 @default.
• W2098839608 countsByYear W20988396082014 @default.
• W2098839608 countsByYear W20988396082015 @default.
• W2098839608 countsByYear W20988396082016 @default.
• W2098839608 countsByYear W20988396082017 @default.
• W2098839608 countsByYear W20988396082018 @default.
• W2098839608 countsByYear W20988396082019 @default.
• W2098839608 countsByYear W20988396082020 @default.
• W2098839608 countsByYear W20988396082021 @default.
• W2098839608 countsByYear W20988396082022 @default.
• W2098839608 countsByYear W20988396082023 @default.
• W2098839608 crossrefType "journal-article" @default.
• W2098839608 hasAuthorship W2098839608A5009859448 @default.
• W2098839608 hasAuthorship W2098839608A5018965634 @default.
• W2098839608 hasAuthorship W2098839608A5021517283 @default.
• W2098839608 hasAuthorship W2098839608A5029899326 @default.
• W2098839608 hasAuthorship W2098839608A5036732236 @default.
• W2098839608 hasAuthorship W2098839608A5043850889 @default.
• W2098839608 hasAuthorship W2098839608A5053399122 @default.
• W2098839608 hasAuthorship W2098839608A5059576786 @default.
• W2098839608 hasAuthorship W2098839608A5076834694 @default.
• W2098839608 hasAuthorship W2098839608A5077814849 @default.
• W2098839608 hasAuthorship W2098839608A5086835868 @default.
• W2098839608 hasAuthorship W2098839608A5088432263 @default.
• W2098839608 hasConcept C126322002 @default.
• W2098839608 hasConcept C164705383 @default.
• W2098839608 hasConcept C2778198053 @default.
• W2098839608 hasConcept C2778292772 @default.
• W2098839608 hasConcept C2778849806 @default.
• W2098839608 hasConcept C2779161974 @default.
• W2098839608 hasConcept C71924100 @default.
• W2098839608 hasConceptScore W2098839608C126322002 @default.
• W2098839608 hasConceptScore W2098839608C164705383 @default.
• W2098839608 hasConceptScore W2098839608C2778198053 @default.
• W2098839608 hasConceptScore W2098839608C2778292772 @default.
• W2098839608 hasConceptScore W2098839608C2778849806 @default.
• W2098839608 hasConceptScore W2098839608C2779161974 @default.
• W2098839608 hasConceptScore W2098839608C71924100 @default.
• W2098839608 hasIssue "1" @default.
• W2098839608 hasLocation W20988396081 @default.
• W2098839608 hasLocation W20988396082 @default.
• W2098839608 hasOpenAccess W2098839608 @default.
• W2098839608 hasPrimaryLocation W20988396081 @default.
• W2098839608 hasRelatedWork W2047344647 @default.
• W2098839608 hasRelatedWork W2067977631 @default.
• W2098839608 hasRelatedWork W2073453392 @default.

• next